作者
Carlos González,Katrina M. Bell,Ramakrishnan Rajagopalan,M. De Silva,Aída Lemes,Cristina Zoco Zabala,Florencia Pérez,Alfredo Cerisola,Arastoo Vossough,Matthew T. Whitehead,C.A. Cunningham,Natasha J. Brown,R O Quin,Cas Simons,Thomas Conway,Eloise Uebergang,Rocío Rius,Meutia Ayuputeri Kumaheri,Emma Kotes,Akbar Vohra,Miranda Pg Zalusky,Zachary B. Anderson,Sophie H. R. Storz,S. Ward,Joy Goffena,Jonas A. Gustafson,Susan M. White,Adeline Vanderver,Danny E. Miller
摘要
Abstract Canavan disease (CD) is a neurodegenerative disorder caused by biallelic disease-causing variants in the ASPA gene. Here, we utilized long-read sequencing (LRS) to investigate eight individuals clinically diagnosed with Canavan disease but without definitive genetic diagnoses. Our analyses identified a recurring previously unreported intronic SVA_E retrotransposon insertion within ASPA in all eight individuals. Surprisingly, the frequency of this variant in population databases suggests it is the most common pathogenic variant in ASPA and should be evaluated in diagnostic testing and carrier screening for CD. Additionally, this finding has implications for the broader rare disease community, as it highlights a substantial blind spot in standard short-read diagnostic pipelines, which historically have missed or overlooked these types of insertions. This discovery highlights the power of emerging technologies, such as LRS and RNA-sequencing (RNA-seq), to bring new classes of variants into diagnostic utility for genetic disorders like CD.